Virtu Financial LLC bought a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) during the 3rd quarter, HoldingsChannel reports. The firm bought 1,993 shares of the insurance provider’s stock, valued at approximately $631,000.
Other hedge funds have also modified their holdings of the company. TD Private Client Wealth LLC raised its stake in shares of Humana by 65.9% during the third quarter. TD Private Client Wealth LLC now owns 2,118 shares of the insurance provider’s stock valued at $671,000 after purchasing an additional 841 shares during the period. Sunbelt Securities Inc. grew its holdings in Humana by 150.3% during the 3rd quarter. Sunbelt Securities Inc. now owns 408 shares of the insurance provider’s stock valued at $129,000 after purchasing an additional 245 shares in the last quarter. Toronto Dominion Bank increased its stake in Humana by 1.3% during the 3rd quarter. Toronto Dominion Bank now owns 59,992 shares of the insurance provider’s stock worth $19,002,000 after buying an additional 754 shares during the period. Coldstream Capital Management Inc. lifted its holdings in Humana by 27.3% in the 3rd quarter. Coldstream Capital Management Inc. now owns 3,318 shares of the insurance provider’s stock worth $1,032,000 after buying an additional 712 shares in the last quarter. Finally, Ashford Capital Management Inc. purchased a new position in Humana in the 3rd quarter valued at about $1,356,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
HUM has been the topic of several recent analyst reports. Stephens reiterated an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Oppenheimer cut their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Jefferies Financial Group cut Humana from a “buy” rating to a “hold” rating and reduced their target price for the company from $519.00 to $253.00 in a research note on Monday, October 7th. KeyCorp initiated coverage on shares of Humana in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, TD Cowen increased their price objective on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $304.15.
Humana Trading Up 0.5 %
Shares of NYSE:HUM opened at $274.12 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $274.13 and its 200 day moving average price is $324.53. The company has a market cap of $33.01 billion, a PE ratio of 24.28, a P/E/G ratio of 2.15 and a beta of 0.53. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $486.00.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Sell-side analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current year.
Humana Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is 31.36%.
About Humana
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
- Five stocks we like better than Humana
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Investors Can Find the Best Cheap Dividend Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.